Two-step liver surgery for colorectal cancer that has spread to the liver
Part of Cancer, Digestive system clinical trials.
This trial studies a two-step surgery called ALPPS for people with colorectal cancer that has spread to the liver. It aims to remove more liver tumors safely by growing the remaining liver first, possibly helping more patients become eligible for surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 74 years old.
- You should be generally active and able to care for yourself (ECOG 0-1).
- You must have colorectal cancer that has spread to the liver.
- Your liver function must be good, measured as Child-Pugh grade A.
- The remaining liver after surgery must be too small, requiring a special two-step surgery.
- You cannot have other cancers (except certain lung metastases) or be pregnant.
- A team of specialists must agree that surgery is right for you.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares liver transplant versus liver surgery for people whose colorectal cancer has spread only to the liver and cannot be removed initially. You would first receive chemotherapy to shrink the tumors, and if they become removable, you may be randomly assigned to have a liver transplant or standard liver surgery.
This trial tests whether a liver transplant can help people with colorectal cancer that has spread to the liver, when the cancer is stable on chemotherapy and can't be treated with local methods. The goal is to offer a potential cure or longer-term control for those who qualify.
This trial tests whether adding two targeted drugs (serplulimab and bevacizumab) to standard chemotherapy before surgery can improve outcomes for people with colorectal cancer that has spread to the liver. It is for those whose cancer has certain genetic features and is considered resectable.
This trial tests whether treating all liver tumors with surgery, ablation, or radiation is better than continuing standard chemotherapy for people with colorectal cancer that has spread only to the liver. It's for those whose liver tumors have been controlled by initial chemotherapy and are considered removable.
This trial looks at a special two-step surgery called ALPPS for people with liver cancer that can't be removed in one operation. The first step helps the liver grow more healthy tissue, and then the second step removes the tumor. The goal is to understand how well this works and how the liver regenerates.
This study compares two different types of liver surgery for people with colorectal cancer that has spread to the liver and who have specific genetic changes or a right-sided primary tumor. You will be randomly assigned to one surgery type, and researchers will track how well you do over time to see if one approach is better.
Hear when a new Colorectal Liver Metastases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.